Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

被引：0

作者：

Chen, Jiaoting ^{[1
]}

Su, Ning ^{[1
]}

Huang, Yan ^{[2
]}

Zhang, Min ^{[3
]}

Yao, Jiayin ^{[3
]}

Li, Guolin ^{[4
]}

Ma, Tenghui ^{[5
]}

Zhi, Min ^{[3
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hematol, Guangzhou, Guangdong, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China

[4] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China

[5] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China

来源：

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2024年 / 116卷 / 03期

关键词：

Indolent T-cell lymphoproliferative disorder; Ulcerative colitis; Tumor necrosis factor-alpha inhibitor; LYMPHOPROLIFERATIVE DISORDER;

D O I：

10.17235/reed.2023.9623/2023

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Indolent T-cell lymphoma is a rare disease. Here we presented a 53-year-old male patient initially diagnosed as ulcerative colitis in 2000 that finally developed into extensive indolent T-cell lymphoma in 2022. We also described the differences between indolent T-cell lymphoma and inflammatory bowel disease, and the possible disease progression into lymphoma after biological therapy.

引用

页码：165 / 166

页数：2

共 5 条

[1] A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
Kotlyar, David S.
Osterman, Mark T.
Diamond, Robert H.
Porter, David
Blonski, Wojciech C.
Wasik, Mariusz
Sampat, Sami
Mendizabal, Manuel
Lin, Ming V.
Lichtenstein, Gary R.
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 36 - U75
[2] Indolent T-cell lymphoproliferative disease of the gastrointestinal tract
Perry, Anamarija M.
Warnke, Roger A.
Hu, Qinglong
Gaulard, Philippe
Copie-Bergman, Christiane
Alkan, Serhan
Wang, Huan-You
Cheng, Jason X.
Bacon, Chris M.
Delabie, Jan
Ranheim, Erik
Kucuk, Can
Hu, XiaoZhou
Weisenburger, Dennis D.
Jaffe, Elaine S.
Chan, Wing C.
[J]. BLOOD, 2013, 122 (22) : 3599 - 3606
[3] Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
Sharma, Ayush
Oishi, Naoki
Boddicker, Rebecca L.
Hu, Guangzhen
Benson, Hailey K.
Ketterling, Rhett P.
Greipp, Patricia T.
Knutson, Darlene L.
Kloft-Nelson, Sara M.
He, Rong
Eckloff, Bruce W.
Jen, Jin
Nair, Asha A.
Davila, Jaime I.
Dasari, Surendra
Lazaridis, Konstantinos N.
Bennani, N. Nora
Wu, Tsung-Teh
Nowakowski, Grzegorz S.
Murray, Joseph A.
Feldman, Andrew L.
[J]. BLOOD, 2018, 131 (20) : 2262 - 2266
[4] Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy
Takahashi, Naoki
Tsukasaki, Kunihiro
Kohri, Mika
Akuzawa, Yu
Saeki, Tsuyoshi
Okamura, Daisuke
Ishikawa, Maho
Maeda, Tomoya
Kawai, Nobutaka
Matsuda, Akira
Arai, Eiichi
Arai, Shin
Asou, Norio
[J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (01) : 7 - 10
[5] Indolent T-Cell Lymphoproliferative Disorder of the Uterine Corpus: A Case Report
Thomas, Sally J.
Morley, Nicholas
Lashen, Hany
Naresh, Kikkeri N.
Fernando, Malee
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (05) : 503 - 506

← 1 →